skip navigation


Register for Latest Research

Stay Informed
Register with NCJRS to receive NCJRS's biweekly e-newsletter JUSTINFO and additional periodic emails from NCJRS and the NCJRS federal sponsors that highlight the latest research published or sponsored by the Office of Justice Programs.

NCJRS Abstract

The document referenced below is part of the NCJRS Virtual Library collection. To conduct further searches of the collection, visit the Virtual Library. See the Obtain Documents page for direction on how to access resources online, via mail, through interlibrary loans, or in a local library.


NCJ Number: 148182 Add to Shopping cart Find in a Library
Journal: Police Chief  Volume:61  Issue:4  Dated:(April 1994)  Pages:20,22-24
Author(s): J McGivney
Date Published: 1994
Page Count: 4
Sponsoring Agency: National Institute of Justice/
Rockville, MD 20849
Sale Source: National Institute of Justice/
NCJRS paper reproduction
Box 6000, Dept F
Rockville, MD 20849
United States of America
Type: Training (Aid/Material)
Format: Article
Language: English
Country: United States of America
Annotation: An agent of the Drug Enforcement Administration (DEA) discusses a new "Made in America" designer drug: methcathinone.
Abstract: Methcathinone ("Cat") has tremendous potential for abuse. Originally patented in Germany in 1928, Cat first appeared in the U.S. in 1957, when an American pharmaceutical firm studied its uses as an appetite suppressant. It first drew the attention of law enforcement in Michigan in 1990 as a drug more powerful than crack. Since then, 33 Cat laboratories have been seized. Cat's effects are similar to those of methamphetamine--feelings of omnipotence and euphoria. It produces increased energy, self-assurance, acute alertness, hyperactivity, talkativeness, and sexual stimulation. Cat is highly addictive; users rapidly develop a tolerance for Cat, and require increasing amounts to achieve the effects. It is usually sold in gram quantities for $75 to $100, and snorted, damaging the nose and causing many users to resort to intravenous or oral ingestion. Manufacture of cat requires little sophistication and only one ingredient that cannot be obtained over the counter: ephedrine. DEA proposed legislation to control the sale of ephedrine; H.R.3216 was signed into law and scheduled to become effective April 16, 1994. 8 endnotes
Main Term(s): Drug abuse
Index Term(s): Computers; Courts; Drug law enforcement; Police
To cite this abstract, use the following link:

*A link to the full-text document is provided whenever possible. For documents not available online, a link to the publisher's website is provided. Tell us how you use the NCJRS Library and Abstracts Database - send us your feedback.